1.
Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through
the brain parenchyma and the clearance of interstitial solutes, including amyloid
beta. Sci Transl Med 2012;4(147):147ra111.
2.
Nedergaard M, Goldman SA. Brain Drain. Sci Am 2016;314(3):44-49.
3.
Boespflug EL, Iliff JJ. The Emerging Relationship Between Interstitial FluidCerebrospinal
Fluid
Exchange,
Amyloid-beta,
and
Sleep.
Biol
Psychiatry
2018;83(4):328-336.
4.
IAEA. "Tracer studies" from web page of International Atomic Energy Agency.
5.
Mardor Y, Rahav O, Zauberman Y, et al. Convection-enhanced drug delivery:
increased efficacy and magnetic resonance image monitoring. Cancer Res
2005;65(15):6858-6863.
6.
Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain.
Science 2013;342(6156):373-377.
7.
Iliff JJ, Lee H, Yu M, et al. Brain-wide pathway for waste clearance captured by
contrast-enhanced MRI. J Clin Invest 2013;123(3):1299-1309.
8.
Gaberel T, Gakuba C, Goulay R, et al. Impaired glymphatic perfusion after strokes
revealed by contrast-enhanced MRI: a new target for fibrinolysis? Stroke
2014;45(10):3092-3096.
9.
Siebner HR, Grafin von Einsiedel H, Conrad B. Magnetic resonance ventriculography
with gadolinium DTPA: report of two cases. Neuroradiology 1997;39(6):418-422;
discussion 422.
10.
Speck U. Gadolinium DTPA for intrathecal use. Neuroradiology 1997;39(6):422.
11.
Samardzic D, Thamburaj K. Magnetic resonance characteristics and susceptibility
weighted imaging of the brain in gadolinium encephalopathy. J Neuroimaging
2015;25(1):136-139.
12.
Arlt S, Cepek L, Rustenbeck HH, Prange H, Reimers CD. Gadolinium
encephalopathy due to accidental intrathecal administration of gadopentetate
dimeglumine. J Neurol 2007;254(6):810-812.
13.
Reeves C, Galang E, Padalia R, Tran N, Padalia D. Intrathecal Injection of
Gadobutrol: A Tale of Caution. J Pain Palliat Care Pharmacother 2017;31(2):139-143.
14.
Provenzano DA, Pellis Z, DeRiggi L. Fatal gadolinium-induced encephalopathy
following accidental intrathecal administration: a case report and a comprehensive
evidence-based review. Reg Anesth Pain Med 2019.
15.
Eide PK. MRI with intrathecal MRI gadolinium contrast medium administration: a
possible method to assess glymphatic function in human brain. Acta Radiologica
Open 2015;4(11):1-5.
16.
Oner AY, Barutcu B, Aykol S, Tali ET. Intrathecal Contrast-Enhanced Magnetic
Resonance Imaging-Related Brain Signal Changes: Residual Gadolinium Deposition?
Invest Radiol 2017;52(4):195-197.
17.
Algin O, Turkbey B. Intrathecal gadolinium-enhanced MR cisternography: a
comprehensive review. AJNR Am J Neuroradiol 2013;34(1):14-22.
18.
DelGaudio JM, Baugnon KL, Wise SK, Patel ZM, Aiken AH, Hudgins PA. Magnetic
resonance cisternogram with intrathecal gadolinium with delayed imaging for
difficult to diagnose cerebrospinal fluid leaks of anterior skull base. Int Forum
Allergy Rhinol 2015;5(4):333-338.
19.
Nacar Dogan S, Kizilkilic O, Kocak B, Isler C, Islak C, Kocer N. Intrathecal
gadolinium-enhanced MR cisternography in patients with otorhinorrhea: 10-year
experience of a tertiary referral center. Neuroradiology 2018;60(5):471-477.
20.
Ringstad G, Vatnehol SAS, Eide PK. Glymphatic MRI in idiopathic normal pressure
hydrocephalus. Brain 2017;140(10):2691-2705.
21.
Taoka T, Jost G, Frenzel T, Naganawa S, Pietsch H. Impact of the Glymphatic System
on the Kinetic and Distribution of Gadodiamide in the Rat Brain: Observations by
Dynamic MRI and Effect of Circadian Rhythm on Tissue Gadolinium Concentrations.
Invest Radiol 2018;53(9):529-534.
22.
van de Haar HJ, Burgmans S, Jansen JF, et al. Blood-Brain Barrier Leakage in
Patients with Early Alzheimer Disease. Radiology 2016;281(2):527-535.
23.
Naganawa S, Nakane T, Kawai H, Taoka T. Gd-based Contrast Enhancement of the
Perivascular Spaces in the Basal Ganglia. Magnetic Resonance in Medical Sciences
2017;16(1):61-65.
24.
Naganawa S, Nakane T, Kawai H, Taoka T. Lack of Contrast Enhancement in a Giant
Perivascular Space of the Basal Ganglion on Delayed FLAIR Images: Implications
for the Glymphatic System. Magn Reson Med Sci 2017;16(2):89-90.
25.
Naganawa S, Nakane T, Kawai H, Taoka T. Differences in Signal Intensity and
Enhancement on MR Images of the Perivascular Spaces in the Basal Ganglia versus
Those in White Matter. Magn Reson Med Sci 2018;17(4):301-307.
26.
Naganawa S, Nakane T, Kawai H, Taoka T. Age Dependence of Gadolinium Leakage
from the Cortical Veins into the Cerebrospinal Fluid Assessed with Whole Brain 3Dreal Inversion Recovery MR Imaging. Magn Reson Med Sci 2019;18(2):163-169.
27.
Absinta M, Ha SK, Nair G, et al. Human and nonhuman primate meninges harbor
lymphatic vessels that can be visualized noninvasively by MRI. Elife 2017;6.
28.
Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central
nervous system lymphatic vessels. Nature 2015;523(7560):337-341.
29.
Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D. High signal intensity in
the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images:
relationship with increasing cumulative dose of a gadolinium-based contrast material.
Radiology 2014;270(3):834-841.
30.
Kanda T, Oba H, Toyoda K, Kitajima K, Furui S. Brain gadolinium deposition after
administration of gadolinium-based contrast agents. Jpn J Radiol 2016;34(1):3-9.
31.
Kanda T. The New Restrictions on the Use of Linear Gadolinium-based Contrast
Agents in Japan. Magn Reson Med Sci 2019;18(1):1-3.
32.
Taoka T, Naganawa S. Gadolinium-based Contrast Media, Cerebrospinal Fluid and
the Glymphatic System: Possible Mechanisms for the Deposition of Gadolinium in
the Brain. Magn Reson Med Sci 2018;17(2):111-119.
33.
Tailor DR, Roy A, Regatte RR, et al. Indirect 17(O)-magnetic resonance imaging of
cerebral blood flow in the rat. Magn Reson Med 2003;49(3):479-487.
34.
Kudo K, Harada T, Kameda H, et al. Indirect Proton MR Imaging and Kinetic
Analysis of (17)O-Labeled Water Tracer in the Brain. Magn Reson Med Sci
2018;17(3):223-230.
35.
Igarashi H, Tsujita M, Kwee IL, Nakada T. Water influx into cerebrospinal fluid is
primarily controlled by aquaporin-4, not by aquaporin-1: 17O JJVCPE MRI study in
knockout mice. Neuroreport 2014;25(1):39-43.
36.
Connor SE, O'Gorman R, Summers P, et al. SPAMM, cine phase contrast imaging
and fast spin-echo T2-weighted imaging in the study of intracranial cerebrospinal
fluid (CSF) flow. Clin Radiol 2001;56(9):763-772.
37.
Sakas DE, Korfias SI, Wayte SC, et al. Chiari malformation: CSF flow dynamics in
the craniocervical junction and syrinx. Acta Neurochir (Wien) 2005;147(12):12231233.
38.
Yamada S, Miyazaki M, Kanazawa H, et al. Visualization of cerebrospinal fluid
movement with spin labeling at MR imaging: preliminary results in normal and
pathophysiologic conditions. Radiology 2008;249(2):644-652.
39.
Yamada S. Cerebrospinal fluid physiology: visualization of cerebrospinal fluid
dynamics using the magnetic resonance imaging Time-Spatial Inversion Pulse
method. Croat Med J 2014;55(4):337-346.
40.
Ohene Y, Harrison IF, Nahavandi P, et al. Non-invasive MRI of brain clearance
pathways using multiple echo time arterial spin labelling: an aquaporin-4 study.
Neuroimage 2019;188:515-523.
41.
Yamashita S, Isoda H, Hirano M, et al. Visualization of hemodynamics in intracranial
arteries using time-resolved three-dimensional phase-contrast MRI. J Magn Reson
Imaging 2007;25(3):473-478.
42.
Yatsushiro S, Sunohara S, Hayashi N, et al. Cardiac-driven Pulsatile Motion of
Intracranial Cerebrospinal Fluid Visualized Based on a Correlation Mapping
Technique. Magn Reson Med Sci 2018;17(2):151-160.
43.
Hirayama A, Matsumae M, Yatsushiro S, Abdulla A, Atsumi H, Kuroda K.
Visualization of Pulsatile CSF Motion Around Membrane-like Structures with both
4D Velocity Mapping and Time-SLIP Technique. Magn Reson Med Sci 2015;14(4):263273.
44.
Takizawa K, Matsumae M, Hayashi N, et al. The Choroid Plexus of the Lateral
Ventricle As the Origin of CSF Pulsation Is Questionable. Neurol Med Chir (Tokyo)
2018;58(1):23-31.
45.
Ichikawa S, Motosugi U, Okumura A, Shimizu T, Onishi H. Measurement of
Cerebrospinal Fluid Flow Dynamics Using Phase Contrast MR Imaging with
Bilateral Jugular Vein Compression: A Feasibility Study in Healthy Volunteers.
Magn Reson Med Sci 2018;17(3):265-268.
46.
Magdoom KN, Zeinomar A, Lonser RR, Sarntinoranont M, Mareci TH. Phase
contrast MRI of creeping flows using stimulated echo. J Magn Reson 2019;299:49-58.
47.
Stejskal EO, Tanner JE. Spin Diffusion Measurements: Spin Echoes in the Presence
of a Time-Dependent Field Gradient. The Journal of Chemical Physics 1965;42:288292.
48.
Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR
imaging of intravoxel incoherent motions: application to diffusion and perfusion in
neurologic disorders. Radiology 1986;161(2):401-407.
49.
Taoka T, Masutani Y, Kawai H, et al. Evaluation of glymphatic system activity with
the diffusion MR technique: diffusion tensor image analysis along the perivascular
space (DTI-ALPS) in Alzheimer's disease cases. Jpn J Radiol 2017;35(4):172-178.
50.
Okudera T, Huang YP, Fukusumi A, Nakamura Y, Hatazawa J, Uemura K. Microangiographical studies of the medullary venous system of the cerebral hemisphere.
Neuropathology 1999;19(1):93-111.
51.
Taoka T, Fukusumi A, Miyasaka T, et al. Structure of the Medullary Veins of the
Cerebral Hemisphere and Related Disorders. Radiographics 2017;37(1):281-297.
52.
Steward C, Venkatraman V, Lui E, et al. Reproducibility of the diffusion of the
perivascular space in older adults with dementia. 27th International Society for
Magnetic Resonance in Medicine. Montreal; 2019. p. 3425.
53.
Cekic M, Yokota H, Ellingson B, Linetsk M, Salamon N. Evaluation of the Glymphatic
System with DTI in Idiopathic Normal Pressure Hydrocephalus. American Society of
Neuroradiology Annual Meeting. Vancouver; 2018. p. O-518.
54.
Harrison IF, Siow B, Akilo AB, et al. Non-invasive imaging of CSF-mediated brain
clearance pathways via assessment of perivascular fluid movement with diffusion
tensor MRI. Elife 2018;7.
55.
Thomas C, Sadeghi N, Nayak A, et al. Impact of time-of-day on diffusivity measures
of brain tissue derived from diffusion tensor imaging. Neuroimage 2018;173:25-34.
56.
Demiral SB, Tomasi D, Sarlls J, et al. Apparent diffusion coefficient changes in
human brain during sleep - Does it inform on the existence of a glymphatic system?
Neuroimage 2019;185:263-273.
57.
Komlosh ME, Benjamini D, Williamson NW, Horkay F, Hutchinson EB, Basser PJ. A
novel MRI phantom to study interstitial fluid transport in the glymphatic system.
Magn Reson Imaging 2019;56:181-186.
58.
Taoka T, Naganawa S, Kawai H, Nakane T, Murata K. Can low b value diffusion
weighted imaging evaluate the character of cerebrospinal fluid dynamics? Jpn J
Radiol 2019;37(2):135-144.
59.
Peng W, Achariyar TM, Li B, et al. Suppression of glymphatic fluid transport in a
mouse model of Alzheimer's disease. Neurobiol Dis 2016;93:215-225.
60.
Shokri-Kojori E, Wang GJ, Wiers CE, et al. beta-Amyloid accumulation in the human
brain after one night of sleep deprivation. Proc Natl Acad Sci U S A
2018;115(17):4483-4488.
61.
Jiang Q, Zhang L, Ding G, et al. Impairment of the glymphatic system after diabetes.
J Cereb Blood Flow Metab 2017;37(4):1326-1337.
62.
Liu Q, Yan L, Huang M, et al. Experimental alcoholism primes structural and
functional impairment of the glymphatic pathway. Brain Behav Immun 2019.
63.
Shen MD, Nordahl CW, Young GS, et al. Early brain enlargement and elevated extraaxial fluid in infants who develop autism spectrum disorder. Brain 2013;136(Pt
9):2825-2835.
64.
Shen MD. Cerebrospinal fluid and the early brain development of autism. J Neurodev
Disord 2018;10(1):39.
65.
Luo C, Yao X, Li J, et al. Paravascular pathways contribute to vasculitis and
neuroinflammation after subarachnoid hemorrhage independently of glymphatic
control. Cell Death Dis 2016;7:e2160.
66.
Jack CR, Jr., Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic
biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010;9(1):119-128.
67.
Jin BJ, Smith AJ, Verkman AS. Spatial model of convective solute transport in brain
extracellular space does not support a "glymphatic" mechanism. J Gen Physiol
2016;148(6):489-501.
68.
Asgari M, de Zelicourt D, Kurtcuoglu V. Glymphatic solute transport does not require
bulk flow. Sci Rep 2016;6:38635.
69.
Albargothy
NJ,
Johnston
DA,
MacGregor-Sharp
M,
et
al.
Convective
influx/glymphatic system: tracers injected into the CSF enter and leave the brain
along separate periarterial basement membrane pathways. Acta Neuropathol
2018;136(1):139-152.
Figure legends
Figure 1: Outline of the glymphatic system and concept of “common space” in the brain.
Figure 1a illustrates that perivascular clearance comprises perivascular drainage and the
glymphatic pathways. Cerebrospinal fluid (CSF) flows into the brain parenchyma via the
periarterial space and enters the interstitial space of the brain tissue via AQP4-controlled water
channels, which are localized to the end feet of astrocytes which form the outer wall of the
perivascular space. CSF entering the interstitial space removes waste proteins from the tissue,
then flows into the perivenous space and is discharged outside the brain.
Figure 1b illustrates the concept of “common space” within the brain. The interstitial and CSF
spaces of the brain are regarded as common space, which act not only as supportive structures but
also function as spaces for mass transport, immune function, or intercellular signal transmission.
The common space is filled with “neurofluids”, a term referring to all types of fluids which
comprise the CNS, including CSF, ISF, and blood, and fluid exchange occurs among these
“neurofluid” compartments.
Figure 2: CSF and brain parenchymal contrast enhancement at multiple time points after
intrathecal GBCA administration
Reconstructed T1-weighted images in sagittal (top row), axial (middle row) and coronal (bottom
row) planes from MRI at baseline (before contrast agent administration) and at four subsequent
imaging time points demonstrating time-dependent contrast enhancement of the subarachnoid and
intraventricular spaces in an iNPH patient (a) and a reference subject (b). Reflux of gadobutrol
into the lateral ventricles is a typical feature of iNPH. In the reference subject, retrodural contrast
enhancement can be seen in the sagittal images (top row) at the 1 h, 3 h and 4.5 h time points and
is indicative of CSF leakage.
Used from reference (20) : Public Domain Material.
Figure 3: GBCA leakage from the cortical veins into the cerebrospinal fluid after
intravenous administration
Images from a 49-year-old woman with suspicion of endolymphatic hydrops (a). These images
were obtained 4 h after intravenous administration of a single dose of gadolinium-based contrast
agent. The CSF around the cortical veins shows a high signal intensity on three-dimensional real
inversion recovery (3D-real IR) images (arrows). Images from a 17-year-old woman with a
suspicion of endolymphatic hydrops (b). Enhancement in the CSF around the cortical veins was
not observed in this young patient.
Used from reference (26) : Public Domain Material.
Figure 4: Distribution of GBCA in the perivascular space after intravenous injection
Magnetic resonance cisternography (MRC) from a 71-year-old woman with suspected
endolymphatic hydrops. There is much perivascular space (PVS) in the bilateral basal ganglia (a,
arrows). In the pre-contrast heavily T2-weighted FLAIR (hT2-FL) images (b), the PVS has a lowsignal intensity. In post-contrast hT2-FL images (c), the PVS has an increased signal intensity
(arrows). The CSF also shows an increased signal. Note that some regions of the PVS have a
higher signal than the CSF.
Used from reference (23) : Public Domain Material.
Figure 5: Hypothesized mechanism of gadolinium deposition via the glymphatic system
Schematic illustrating our hypothesis for gadolinium deposition. Compared with GBCA in
systemic circulation, GBCA that is distributed into the CSF cavity via the glymphatic system can
remain in brain tissue for an extended period of time. The authors of this review speculate that
the glymphatic system may contribute to the tissue deposition of gadolinium.
Used from reference (32) : Public Domain Material.
Figure 6: Dynamic curves of relative signals after injection of 17O-labeled water
Dynamic curves of relative signal intensity. A bolus injection of saline or 17O was initiated 120 s
after starting a scan. Significant drops in signal were observed in the cerebral cortex (a), choroid
plexus (d), ventricle (e), and subarachnoid space (f) in the
17
O condition, while only slight
reductions in signal were noted in the basal ganglia/thalamus (b) and white matter (c). In the
cerebral cortex, choroid plexus, and subarachnoid space, the curves are characterized by two
phases: an initial signal drop and a plateau phase. In the ventricle, the signals gradually and
continuously decreased during the acquisition window.
Used from reference (34) : Public Domain Material.
Figure 7: Concept behind the method of diffusion tensor image analysis along the
perivascular space (DTI-ALPS) and outcomes in cases of Alzheimer’s disease
(a) Roentgenogram of an injected coronal brain slice showing parenchymal vessels that run
horizontally within the slice (white box) at the level of the lateral ventricle body. Reproduced with
permission from reference (50). (b) Axial SWI within the slice at the level of the lateral ventricle
body indicates that parenchymal vessels run laterally (x-axis). (c) Superimposed color display of
DTI onto the SWI (b) showing the distribution of projection fibers (z-axis, blue), association
fibers (y-axis, green), and subcortical fibers (x-axis, red). Three ROIs were placed in the area with
the projection fibers (projection area), association fibers (association area) and subcortical fibers
(subcortical area) to measure diffusivities in the three directions (x, y, z). (d) Schematic indicating
the relationship between the orientation of the perivascular space (gray cylinders) and the
directions of the fibers. Note that the orientation of the perivascular space is perpendicular to both
the projection and association fibers. (e-g) Correlation between directional diffusivity and MMSE
scores for the three directions of the three areas (projection, e; association, f; subcortical, g).
Diffusivity of the x-axis is plotted in red, y-axis in green, and z-axis in blue. Regression lines are
also shown in the same colors with the plots, accompanied by values for the correlation coefficient.
Statistically significant correlations are shown as asterisks. In the projection area (e), we found a
significant positive correlation between the diffusivity along the perivascular space (x-axis) and
MMSE scores. In the association area (f), we found a significant positive correlation between the
diffusivity along the perivascular space (x-axis) and MMSE scores. Conversely, there was a
significant negative correlation between the diffusivity along the projection fibers (z-axis) in the
projection area and MMSE scores. There was also a significant negative correlation between the
association fibers (y-axis) in the association area and MMSE scores. These negative correlations
may be explained by white matter degeneration in the projection or association fibers due to AD
or MCI. (h) Correlation between the ALPS-index and MMSE. Correlations between MMSE and
the ALPS-index determined by the following ratio are shown:
ALPS-index = mean (Dxproj, Dxassoc)/mean (Dyproj, Dzassoc).
There was a significant positive correlation (r = 0.46, p = 0.0084) between the ALPS-index and
MMSE scores.
Used from reference (49) with permission.
Arteries
CSF
CSF
Waste
Basement membrane
Veins
AQP4
Basement membrane
Figure 1
Glia cells
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Intravenous administration
Choroid plexus? Cranial nerve endings?
Capillaries surrounding perivascular space?
Venous wall?
Cervical
Lymphatic
system
Cerebrospinal
fluid
Perivascular space
(Artery)
Glymphatic
system
Interstitial
space
Tissue deposition
Perivascular space
(Vein)
Macrocyclic GBCA:Chelate is stable
Linear GBCA: Possibility of de-chelation
Figure 7
Figure 8
Projection area
Subcortical
area
Perivascular space
Association area
1.5
r=0.40*
0.5
r=0.50*
0.5
r=-0.32
r=-0.13
0.5
r=-0.10
r=-0.24
20
ADC(mm2/s)
10
r=-0.35
r=-0.55*
ADC(mm2/s)
ADC(mm2/s)
r=-0.62*
30
10
20
30
10
20
MMSE
MMSE
MMSE
Subcortical area
1.5
1.5
Association area
Association area
Projection area
Projection area
30
Dx
Dy
Dz
Subcortical area
...